EFDID: 373888EFD: View Filing

Issuer: Maxona Pharmaceuticals, Inc. (0001857448) - D

Accession: 0001857448-21-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001857448
  • Entity Name:
    Maxona Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    300 VILLAGE DRIVE
    SUITE 719
    KING OF PRUSSIA, PA 19406
  • Persons:
    Related Persons 3
    Shahin Fatholahi
    Executive Officer, Director
    Behshad Sheldon
    Director
    David Nakamura
    Director
EDGAR: Offering Information
  • Accession Date:
    05/05/2021
  • First Sale Date:
    04/09/2021
  • Offering Amount:
    $10,000,000
  • Amount Sold:
    $5,555,000
  • Amount Remaining:
    $4,445,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Arcadia Securities, LLC 44656 None None AK, AZ, CA, CO, CT, FL, IL, MD, MA, MI, NJ, NY, OR, PA, SC, TX, WY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Maxona Pharmaceuticals, Inc./s/ Shahin FatholahiShahin FatholahiChief Executive Officer2021-05-05